Informations bibliographiques
Ligne directriceWHO recommendations on the management of sickle cell disease during pregnancy, childbirth and the interpregnancy period
Année de publication2025
Institution émettriceWorld Health Organization
Recommandation
Nouvelle
For pregnant women with sickle-cell disease (SCD) (not hospitalized), consider additional risk factors for thromboembolism (e.g. prior venous thromboembolism (VTE) following vaso-occlusive events) and follow local recommendations for initiation of thromboprophylaxis for pregnant women with elevated risk of thrombotic events (e.g. prior VTE, obesity, inherited thrombophilia).
Recommandé